LONGBOARD PHARMACEUTICALS INC

NASDAQ: LBPH (Longboard Pharmaceuticals, Inc.)

Last update: 10 Feb, 10:35PM

19.75

0.43 (2.23%)

Market Trend

Short Term Medium Term
Industry Biotechnology (US) Bullish Bullish
Biotechnology (Global) Bullish Bullish
Stock Longboard Pharmaceuticals, Inc. - -

Longboard Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases. The company is working to improve a portfolio of centrally acting product candidates designed to be selective for specific G protein-coupled receptors (GPCRs). The company is evaluating LP352, an oral, centrally acting 5-hydroxytryptamine 2C (5-HT2C) receptor superagonist, with negligible observed impact on 5-HT2B and 5-HT2A receptor subtypes, in development for the potential treatment of seizures associated with a broad range of developmental and epileptic encephalopathies.

Sector Healthcare
Industry Biotechnology
Investment Style Small Value

Ownership

Name Date Shares Held
Integral Health Asset Management, Llc 30 Sep 2023 760,000
Parkman Healthcare Partners Llc 30 Sep 2023 355,957
52 Weeks Range
3.60 - 28.15
Price Target Range
40.00 - 60.00
High 60.00 (HC Wainwright & Co., 203.80%) Buy
60.00 (Cantor Fitzgerald, 203.80%) Overweight
Median 60.00 (203.80%)
Low 40.00 (Citigroup, 102.53%) Buy
Average 53.33 (170.04%)
Total 2 Buy, 1 Overweight
Firm Date Target Price Call Price @ Call
Citigroup 16 Feb 2024 40.00 (102.53%) Buy 21.27
Cantor Fitzgerald 16 Jan 2024 60.00 (203.80%) Overweight 23.00
HC Wainwright & Co. 08 Jan 2024 60.00 (203.80%) Buy 24.94

No data within this time range.

Portfolio

Template

Your price alert

Risk Profile

| | | | |
Conservative
Moderate Conservative
Moderate
Moderate Aggressive
Aggressive
Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)

Disclaimer: The above is for illustrative purposes only and is NOT investment advice. Seek advice from a qualified financial professional.

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

52W Range
 
52WL
 
52WH
SL
EP
TP1
TP2

All alert prices are within 52 weeks price range

Realized Profit -
Unrealized Profit -
Dividend Received 2024 -
Total Profit -
Avg. Return -
Quantity (Buy) -
Avg. Price (Buy) -
Quantity (Sold) -
Avg. Price (Sold) -
No data